Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 348 participants.
Also called NCT01427920
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 348 participants
- Sponsor
- Registry
-
NCT01427920 -
2010-024303-27
-
- Other papers using this trial's data
- The SimpleMix study with biphasic insulin aspart 30: a randomized controlled trial investigating patient-driven titration versus investigator-driven titration
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Argentina, China, India, Poland, Spain, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01427920. Randomized; no masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2012-07 (actual). Results posted on 2013-09-12.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes
- Acronym
- SimpleMix™
- Condition
- Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- biphasic insulin aspart 30
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct01427920- Content hash
2a9c47eb24ee75cfb707811c77c853e8def944c6ed2ec3700b313236867d9308